In addition, DBS also provides an alternative tool to formalin-fixed paraffin-embedded cell blocks for biobanking to detect epidermal growth factor receptor (EGFR) or Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) mutation for personalized target therapy in lung cancer patients [28]. This evidence concerns the gene KRAS and lung carcinoma.